EU regulator warns on possible MS drugs side effects
August 20, 2014 at 12:14 PM EDT
FRANKFURT, Aug 20 (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs.
